Cardiology electrodes Market is segmented By Product (Resting ECG electrodes, Short-term monitoring ECG electrodes, Long-term monitoring ECG electrodes, Stress test ECG electrodes, Neonatal ECG electrodes), By Procedure (Electrocardiography (ECG), Electroencephalography (EEG), Electromyography (EMG)), By Usability (Disposable medical electrodes, Reusable medical electrodes), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Cardiology Electrodes Market Overview
[200 pages] Report analyses the Global Cardiology electrodes Market shares, recent trends, and market player analysis. The market is estimated to reach a CAGR of 4.6% during the forecast period 2024 - 2031. North america region will dominate the cardiology electrodes market. The Competitive rivalry intensifies with Asahi Kasei Corporation, Ambu A/S and Rhythmlink International LLC.
Cardiac electrodes are small, plastic patches that stick to the skin. They are placed at certain spots on the chest, legs and arms. The electrodes are connected by lead wires to an ECG machine. The heart’s electrical activity is then measured, interpreted and printed out. No electricity is sent into the body.
Cardiology Electrodes Market Scope
Metrics |
Details |
Market CAGR |
4.6% |
Segments Covered |
By Product, By Procedure, By Usability, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
For More Insights Download Sample
Cardiology Electrodes Market Dynamics
The increasing prevalence of neurological and cardiovascular diseases will drive the market. Increasing demand for disposable electrodes will drive the cardiology electrodes market in the forecast period.
The increasing prevalence of neurological and cardiovascular diseases will drive the market
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Cardiovascular diseases are a group of heart and blood vessels disorders and include coronary heart disease, rheumatic heart disease, cerebrovascular disease and other conditions.
Cardiovascular diseases are diagnosed by using an array of laboratory tests and imaging studies. EKG/ECG (Electrocardiogram) is a simple painless test that helps in recording the electrical activity of the heart. The patient is strapped to the instrument with several patches or leads placed over their chest, ankles and wrists. ECG/ECG (Electrocardiogram) is a portable machine which is small. It records the heart’s activities on a graph paper strip. The test shows how fast the heart beats and its rhythm. The timing and strength of the electrical signals as they pass through the heart are also seen. An EKG/ECG can help detect a heart attack, attacks of angina, arrhythmias, etc.
Up to 1 billion people, nearly one in six of the world's population, suffer from neurological disorders.
Increasing demand for disposable electrodes will drive the cardiology electrodes market in the forecast period
The disposable medical electrode includes a disk formed of a semi-rigid plastic material with a recessed embossment located centrally. The disk has an adhesive applied to it for firmly securing the electrode to the patient's skin. The usage of new disposable electrodes for each recording offers the advantage of avoiding reusable cleaning electrodes. Hence, it will drive the cardiology electrodes market in the forecast period.
BIOPAC’s disposable EL500 series electrodes offer a fast, easy, and more hygienic alternative to reusable electrodes. EL500 series electrodes are available as pre-gelled or dry surface electrodes with snap connector with cloth, foam, long-term, paired, RT, Bioimpedance, and EDA options. EL500 Series snap electrodes provide the same signal transmission as BIOPAC’s reusable electrodes, with added convenience and hygiene. Each peel-and-stick disposable electrode is designed for one use only.
On August 7, 2020FDA approved Kendall Multifunction Defibrillation Electrodes, MEDI-TRACE Cadence Defibrillation Electrodes, Physio-Control/Stryker QUIK-COMBO Pacing/Defibrillation/ECG Electrodes.
The high sterilization price of reusable electrodes will hamper the market
As a potential source of Disposable medical electrodes acquired infection (HAI), reusable electroencephalographic (EEG) electrodes are under investigation. As the traditional EEG procedure involves abrasion of the skin, these electrodes are considered semi-critical devices.They require sterilization or high-level disinfection. Improperly cleaned reusable cup electrodes may harbor bacteria, blood, and microscopic epithelial cells. And can lead to a break in the skin which occurs when applying EEG scalp electrodes. It creates the risk of infection from blood-borne pathogens such as HIV, Hepatitis-C, and Creutzfeldt-Jacob Disease.
The health care facilities that use medical devices, including semi-critical devices are inspected by Occupational Safety and Health Administration (OSHA). OSHA can cite violations and assign fines for non-compliance with regulations such as the Bloodborne Pathogen Standard .Fines range from $250.00 to $70,000.00 per single violation. Thus, institutions that use reusable EEG electrodes and fail to clean the devices properly after its use in between patients are at risk of substantial fines and penalties.
COVID-19 Impact on Cardiology Electrodes Market
Disposable medical electrodes s and medical practices have been affected during the COVID 19 pandemic due to several protocols. The ECG/EKG procedures for diagnosis and monitoring the heart involved in this pandemic have been affected. As people are scared to undergo diagnosis for heart diseases due to the risk of COVID-19, there has been an impact on the Cardiology electrodes Market
Resting ECG electrodes will drive the cardiology electrodes market
Resting ECG electrodes are the standard in diagnostic electrodes. They have superior silver/silver chloride technology and quality construction produce an electrode that performs every time. Excellent adhesion and clear traces mean no repeat testing. The unique needs of resting ECG monitoring are met with the 3M family of electrodes designed for short-term diagnostics.Resting ECG electrodes are easy to apply and remove, a tab is convenient for lead wire placement, superior adhesion with the flexibility to reposition as needed. Intimate skin contact ensures accurate EKG traces even on challenging sites and can continue to be used after defibrillation.
The electrocardiography (ECG) segment will dominate the market
One of the fastest and simplest test used to evaluate the heart is Electrocardiogram (ECG). Electrodes are small plastic patches that stick to the skin. They are placed at certain spots on the chest, legs and arms. They are connected by lead wires to an ECG machine. The electrical activity of the heart is then measured, interpreted, and printed out.
AliveCor announced the clearance of new iteration of their KardiaMobile device by Food and Drug Administration (FDA). The KardiaMobile 6L is the first 6-lead personal electrocardiogram (ECG) device. KardiaMobile is a portable ECG reader that works with smartphones and tablets; recently, the device received expanded approval to detect bradycardia and tachycardia. The KardiaMobile 6L adds a third electrode (in addition to 2 electrodes for both thumbs) for the left knee or ankle, allowing for a greater view of electrical activity in the heart. This forms an inverted triangle of electrodes known as the Einthoven Triangle or a 6-lead ECG.
Disposable medical electrodes will dominate the cardiology electrodes market
EEG disposable medical electrodes offer various advantages. They are easy to use and can be disposable, making them ideal for clinical or laboratory applications. These are the only types of electrodes that are commonly used in clinical research studies. A microphone is used to record the brain waves of the person being tested, which is connected to an EEG recording device. The electrodes are put on top of the head and then covered with a cloth to not get thrown off and cause discomfort. EEG disposable medical electrodes are less expensive than portable devices. While a portable device can be quite bulky, it is also heavier to carry around. A disposable item is easy to take along and is usually quite small and lightweight, allowing it to be easily folded or packed into a briefcase.
Global Cardiology Electrodes Market Geographical Analysis
North America will dominate the market
This region will dominate the cardiology electrodes market due to the growing number of ECG procedures, and the rising incidence of CVD’s and their associated risks will rise the market.
In the United States, heart disease is one of the leading cause of death for women, men, people of most racial and ethnic groups. One person dies every 36 seconds from cardiovascular disease in the U.S. Around 655,000 Americans die from heart disease each year that's 1 in every four deaths. At least 48 % of adults have some form of cardiovascular disease, based on the latest statistics provided by the American Heart Association.
Cardiology Electrodes Market Players and Competitive Landscape
The major key players in the cardiology electrodes market are 3M, ADShort-term monitoring ECG electrodes Pty Ltd., EMOTIV, Bionen S.a.s, Ambu A/S, NeuroSky, Asahi Kasei Corporation, Rhythmlink International, LLC, Leonhard Lang USA, Inc., VectraCor Inc., NeuroTherapeutics, Cardinal Health, Medtronic, CONMED Corporation, Vermed Inc., DCC Plc, General Electric, Natus Medical Incorporated., Koninklijke Philips N.V., SOMNOmedics GmbH, and Nissha Co. Ltd.
Rhythmlink International, LLC
Overview: Rhythmlink International, LLC designs, manufactures, distributes medical devices, provides custom packaging, private labeling, custom products, and contract manufacturing solutions to its customers. It provides the important physical connection between patients and the diagnostic equipment to record or elicit neurophysiologic biopotentials. Based in Columbia, SC, Rhythmlink was established in 2002 and is owned and operated by CEO Shawn Regan and COO Michael O’Leary.It is recognized both on a national and international scale because of its improvements in technology, advancements, business development, and corporate branding.
Product Portfolio: Rhythmlink International, LLC, specialties include Medical Device Manufacturing, Custom Packaging, Private Labeling, Custom Product Design, Contract Manufacturing, and Consulting
Key Development: On march 15th, 2021, Rhythmlink International LLC received U.S. Food and Drug Administration (FDA) clearance for a new portfolio of electrodes.
The Cardiology electrodes Market report would provide an access to an approx. 60 market data table, 52 figures and 200 pages.